Video: David Lazarus on a tough choice for diabetics

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts.

UnitedHealthcare is raising the price of NovoLog by 250% while lowering the price of a similar drug, Humalog. The shift will force those on NovoLog to make difficult choices, consumer columnist David Lazarus says, and also shows how out of whack the healthcare system is.

Here’s a link to David’s columns.

--Pat Benson